Jane Street Group, LLC Karuna Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	BUY	$98.9 - $132.37 $2.12 Million - $2.83 Million	21,400 Added 113.83%	40,200 $5.1 Million
Q4 2021 Feb 15, 2022	BUY	$110.64 - $159.4 $1.68 Million - $2.42 Million	15,200 Added 422.22%	18,800 $2.46 Million
Q3 2021 Nov 16, 2021	SELL	$101.2 - $125.87 $111,320 - $138,457	-1,100 Reduced 23.4%	3,600 $440,000
Q2 2021 Aug 16, 2021	BUY	$107.45 - $135.95 $96,705 - $122,354	900 Added 23.68%	4,700 $536,000
Q1 2021 May 18, 2021	SELL	$95.46 - $133.08 $983,237 - $1.37 Million	-10,300 Reduced 73.05%	3,800 $457,000
Q2 2020 Aug 17, 2020	BUY	$62.14 - $117.21 $876,174 - $1.65 Million	14,100 New	14,100 $1.57 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.